Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma
Pharmacogenetics and Genomics
Saved in:
Main Authors: | Lee, S.-C., Soo, R., Guo, J.-Y., Goh, B.-C., Lim, S.-G., Putti, T., Soong, R., Hsieh, W.-S., Tao, Q. |
---|---|
Other Authors: | PATHOLOGY |
Format: | Article |
Published: |
2012
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/33163 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
by: Lim, Chwee Ming, et al.
Published: (2022) -
Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach
by: Salto-Tellez, M., et al.
Published: (2014) -
EXPLORING RECEPTOR TYROSINE KINASES IN THE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: BHAVE SAYALI SHRIVARDHAN
Published: (2023) -
Endofin is a novel component in EGR/EGFR oncogenic signaling
by: TOY WEIYI
Published: (2011) -
Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: A multicentre immunohistochemical study in the Asia-Pacific region
by: Putti, T.C., et al.
Published: (2012)